2024/12/05 by Alexander Sundermann, Rossana Rosa, Patrick N. A. Harris +9 · 1 voice · 5 citations
Agricultural and Biological Sciences · Medicine · Social Sciences · #Salmonella and Campylobacter epidemiology #Zoonotic diseases and public health #Vaccine Coverage and Hesitancy
paper · doi:10.1128/aac.01479-24
Pathogen genomic surveillance in healthcare has the potential to enhance patient safety by detecting outbreaks earlier, thereby reducing morbidity and mortality. Despite benefits, there are barriers to adoption, including cost, expertise, and lack of standardized methodologies and incentives. This commentary advocates for 1) investment from healthcare payors, public health, and regulatory bodies and 2) additional research on genomic surveillance for improving patient outcomes and reducing infections. Effective implementation will require strategic investment and cross-sector collaboration.